Ceylon Hospitals Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Ceylon Hospitals has been growing earnings at an average annual rate of 4.1%, while the Healthcare industry saw earnings growing at 18.5% annually. Revenues have been growing at an average rate of 11.4% per year. Ceylon Hospitals's return on equity is 4.9%, and it has net margins of 4.6%.
Belangrijke informatie
4.1%
Groei van de winst
3.4%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 16.6% |
| Inkomstengroei | 11.4% |
| Rendement op eigen vermogen | 4.9% |
| Nettomarge | 4.6% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Ceylon Hospitals geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 9,189 | 419 | 3,377 | 0 |
| 31 Mar 24 | 9,153 | 417 | 3,302 | 0 |
| 31 Dec 23 | 8,942 | 270 | 3,304 | 0 |
| 30 Sep 23 | 8,786 | 254 | 3,209 | 0 |
| 30 Jun 23 | 8,461 | 407 | 3,057 | 0 |
| 31 Mar 23 | 7,905 | 572 | 2,878 | 0 |
| 31 Dec 22 | 7,780 | 747 | 2,730 | 0 |
| 30 Sep 22 | 7,440 | 980 | 2,632 | 0 |
| 30 Jun 22 | 7,605 | 973 | 2,776 | 0 |
| 31 Mar 22 | 7,841 | 982 | 2,854 | 0 |
| 31 Dec 21 | 7,581 | 906 | 2,864 | 0 |
| 30 Sep 21 | 7,174 | 844 | 2,782 | 0 |
| 30 Jun 21 | 6,528 | 775 | 2,569 | 0 |
| 31 Mar 21 | 5,546 | 560 | 2,337 | 0 |
| 31 Dec 20 | 5,133 | 453 | 2,301 | 0 |
| 30 Sep 20 | 5,379 | 375 | 2,419 | 0 |
| 30 Jun 20 | 5,481 | 332 | 2,496 | 0 |
| 31 Mar 20 | 5,976 | 403 | 2,677 | 0 |
| 31 Dec 19 | 6,064 | 405 | 2,677 | 0 |
| 30 Sep 19 | 5,877 | 322 | 2,621 | 0 |
| 30 Jun 19 | 5,766 | 292 | 2,573 | 0 |
| 31 Mar 19 | 5,806 | 322 | 2,514 | 0 |
| 31 Dec 18 | 5,798 | 455 | 2,447 | 0 |
| 30 Sep 18 | 5,684 | 412 | 2,404 | 0 |
| 30 Jun 18 | 5,686 | 397 | 2,376 | 0 |
| 31 Mar 18 | 5,733 | 402 | 2,361 | 0 |
| 31 Dec 17 | 5,696 | 323 | 2,343 | 0 |
| 30 Sep 17 | 5,623 | 320 | 2,307 | 0 |
| 30 Jun 17 | 5,531 | 329 | 2,248 | 0 |
| 31 Mar 17 | 5,289 | 328 | 2,182 | 0 |
| 31 Dec 16 | 5,152 | 343 | 2,121 | 0 |
| 30 Sep 16 | 5,078 | 400 | 2,051 | 0 |
| 30 Jun 16 | 4,850 | 394 | 1,977 | 0 |
| 31 Mar 16 | 4,728 | 429 | 1,898 | 0 |
| 31 Dec 15 | 4,526 | 316 | 1,815 | 0 |
| 30 Sep 15 | 4,379 | 274 | 1,737 | 0 |
| 30 Jun 15 | 4,217 | 259 | 1,675 | 0 |
| 31 Mar 15 | 4,083 | 200 | 1,640 | 0 |
| 31 Dec 14 | 4,003 | 210 | 1,597 | 0 |
| 30 Sep 14 | 3,905 | 190 | 1,583 | 0 |
| 30 Jun 14 | 3,947 | 182 | 1,560 | 0 |
| 31 Mar 14 | 3,961 | 192 | 1,544 | 0 |
| 31 Dec 13 | 3,933 | 265 | 1,517 | 0 |
Kwaliteitswinsten: CHL.X0000 has a large one-off gain of LKR121.0M impacting its last 12 months of financial results to 30th June, 2024.
Groeiende winstmarge: CHL.X0000's current net profit margins (4.6%) are lower than last year (4.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: CHL.X0000's earnings have grown by 4.1% per year over the past 5 years.
Versnelling van de groei: CHL.X0000's earnings growth over the past year (3.1%) is below its 5-year average (4.1% per year).
Winst versus industrie: CHL.X0000 earnings growth over the past year (3.1%) did not outperform the Healthcare industry 6.6%.
Rendement op eigen vermogen
Hoge ROE: CHL.X0000's Return on Equity (4.9%) is considered low.